1. Nagaki Y et al., Effects of astaxanthin on accommodation, critical flicker fusions, and pattern visual evoked potential in
visual display terminal workers. J Trad Med. 2002;19:170-73.
2. Nakamura A et al., Changes in Visual Function Following Peroral Astaxanthin. Jpn J Clin Opthalmol. 2004;58:1051-54.
3. Nitta T et al., Effects of astaxanthin on accommodation and asthenopia – Dose finding study in healthy volunteers. J Clin Therap Med. 2005;21(5):534-56.
4. Nagaki Y et al.,The supplementation effect of astaxanthin on accommodation and asthenopia. J Clin Therap Med. 2006;22:41-54.
5. Nagaki Y et al., Effect of astaxanthin on accommodation and asthenopia. Folia Ophthalomogica Japonica. 2010;3(5):461-68.
6. Saito M et al., Astaxanthin increases choroidal blood fow velocity. Graefes Arch Clin Exp Ophthalmol. 2012;250:239-45.
7.Nagaki Y., et al. The Effect of Astaxanthin on Retinal Capillary Blood Flow in Normal Volunteers. J Clin Therap Med. 2005;21(5):537-542
8. Shiratori K, Ohgami K, Nitta T, Shinmei Y, Chin S, Yoshida K, Tsukahara H, Takehara I, Ohno S. (2005). Effect of astaxanthin on accommodation and asthenopia – Efficacy identification study in healthy volunteers. J. Clin. Therap. Med., 21(5):543-556. Sussman M. (2001) Total Health At The Computer, Station Hill, New York.

[1] Dr. Tóth Eszter szemész szakorvos válaszai rokuswebpatika.hu weboldal által készített interjú során link
[2] Prentiss, D.: Preventing ultraviolet radiation hazards. = Water Environment and Technology, 16. k. 4. sz. 2004. p. 39–40. Minter, S.: Targeting your eye protection program. = Occupational Hazards, 66. k. 2. sz. 2004. p. 29–30. Sliney, D. H.: Photoprotection of the eye – UV radiation and sunglasses. = Journal of Photochemistry and Photobiology B: Biology, 64. k. 2–3. sz. 2001. nov. 15. p. 166–175.
[3] WEBBeteg – Dr. Papp Júlia, szemész szakorvos link
[5] Krinsky, N. I., Johnson, E. J.: Carotenoid actions and their relation to health and disease. Mol. Asp. Med., 2005, 26, 459-516.
[6] Hussein G et al. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 2006 Mar;69(3):443-9.
[7] Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008 Feb;115(2):324-33 e2.
[8] Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol. 2008 Oct;60(10):1365-74.
[9] Suzuki Y, Ohgami K, Shiratori K, et al. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. Exp Eye Res. 2006 Feb;82(2):275-81.
[10] Izumi-Nagai K, Nagai N, Ohgami K, et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85.
[11] Nagaki Y et al. Effects of astaxanthin on accommodation, critical flicker fusion, and pattern visual evoked potential in visual display terminal workers. Journal of Traditional Medicines. 2002; 19(5):170-73.
[12] Elérhető http://sciencelinks.jp/j-east/article/200512/000020051205A0483229. php. October 27, 2008.
[13] Moeller SM, Voland R, Tinker L, Blodi BA, Klein ML, Gehrs KM, Mares JA. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women’s Health Initiative. Archives of ophthalmology. Mar 2008;126(3):354-364.
[14] Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition (Burbank, Los Angeles County, Calif.). Jan 2003;19(1):21-24